Molecular Imaging: Page 103

SNMMI confirms Medicare reimbursement error for Cerianna

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) said that the U.S. Centers for Medicare and Medicaid Services has confirmed that an inaccurate reimbursement rate had been published in January for Zionexa's Cerianna radiopharmaceutical.

February 23, 2021

Japan scientists separate oxygen molecules used in PET

By AuntMinnie.com staff writers

Japanese researchers have discovered that nanoporous carbon can separate the isotope oxygen-18 from oxygen-16, which is an essential isotope for PET diagnosis.

February 21, 2021

PET aids in treatment of metastatic breast cancer patients

By AuntMinnie.com staff writers

PET imaging performed with the radiolabeled F-18 fluoroestradiol radiotracer can determine whether patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer can benefit from specific treatments, according to new research.

February 17, 2021

Theragnostics, German hospital to study THG-008 for PET

By AuntMinnie.com staff writers

Theragnostics and Essen University Hospital in Germany will study the investigational agent THG-008 for use in PET imaging of a range of cancers.

February 16, 2021

Flortaucipir-PET scans show near-term dementia risk

By Wayne Forrest

Imaging specialists who visually interpreted flortaucipir-PET images were able to determine a person's risk of progressing to Alzheimer's and mild cognitive impairment within the next 18 months in a recent study.

February 16, 2021

PET scans show early link between heart disease, brain function

By Brian Casey

PET scans demonstrate that middle-aged individuals with early signs of cardiovascular disease also have reduced brain metabolism, according to researchers from Spain. The findings indicate that the early stages of Alzheimer's disease could begin years before dementia occurs.

February 15, 2021

SmartBreast joins forces with FITI

By AuntMinnie.com staff writers

On the heels of its acquisitions of molecular breast imaging (MBI) assets from GE Healthcare and Dilon Diagnostics, SmartBreast has signed on FoxSemicon Integrated Technologies (FITI) to manufacture its new MBI systems.

February 8, 2021

RadQual signs distribution deal with LEA

By AuntMinnie.com staff writers

Radioisotope manufacturer International Isotope's RadQual nuclear medicine quality-control subsidiary has signed a North American licensing agreement with French calibration equipment provider Laboratoire d'Etalons d'Activite (LEA).

February 8, 2021

SNMMI, Zionexa call out CMS for reimbursement error

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is teaming up with Zionexa to urge the U.S. Centers for Medicare and Medicaid Services (CMS) to properly reimburse Cerianna, a radiolabeled F-18 fluoroestradiol radiotracer indicated for use with PET.

February 7, 2021

Blue Earth touts fluciclovine F-18 research at ASCO GU

By AuntMinnie.com staff writers

Bracco molecular imaging subsidiary Blue Earth Diagnostics is highlighting research on its Axumin (fluciclovine F-18) PET radiopharmaceutical at the upcoming American Society for Clinical Oncology Genitourinary (ASCO GU) virtual meeting.

February 7, 2021

SmartBreast buys molecular breast imaging business from GE

By Brian Casey

Breast cancer screening firm SmartBreast has acquired assets related to the Discovery NM750b molecular breast imaging (MBI) business of GE Healthcare, including scanner designs, patents, and service contracts for GE's MBI installed base.

February 7, 2021

SPECT spots differences in dementia subtype, Alzheimer's

By Rebekah Moan

A study 20 years in the making reveals that SPECT combined with the radioactive compound iodine-123 FP-CIT distinguishes dementia with Lewy bodies from Alzheimer's disease. Dementia with Lewy bodies is what is believed to have led to actor Robin Williams' suicide.

February 7, 2021

Previous Page

Page 103 of 614

Next Page